Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.
Clinical trial NCT05154201 · COMPLETED
Trial details
- NCT number
- NCT05154201
- Sponsor
- Orinove, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2023-01-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.